Immuno-Oncology Stocks Soar
Markets & Money Today | 2 Min News | The Daily News Now! - Ein Podcast von The Daily News Now! - Montags
Kategorien:
Immuno-oncology industry thrives with precision medicine and AI, but faces challenges like drug pricing scrutiny and competition. Four key stocks reported impressive Q3 revenues, beating analyst expectations by an average of 27%. Exact Sciences, Incyte, and Natera led the pack with significant revenue growth and stock price increases.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.
